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Abstract
Polymorphic variants of DNA repair and damage response genes play major role in carcinogenesis. These variants are
suspected as predisposition factors to Oral Squamous Cell Carcinoma (OSCC). For identification of susceptible variants
affecting OSCC development in Indian population, the ‘‘maximally informative’’ method of SNP selection from HapMap data
to non-HapMap populations was applied. Three hundred twenty-five SNPs from 11 key genes involved in double strand
break repair, mismatch repair and DNA damage response pathways were genotyped on a total of 373 OSCC, 253
leukoplakia and 535 unrelated control individuals. The significantly associated SNPs were validated in an additional cohort
of 144 OSCC patients and 160 controls. The rs12515548 of MSH3 showed significant association with OSCC both in the
discovery and validation phases (discovery P-value: 1.43E-05, replication P-value: 4.84E-03). Two SNPs (rs12360870 of
MRE11A, P-value: 2.37E-07 and rs7003908 of PRKDC, P-value: 7.99E-05) were found to be significantly associated only with
leukoplakia. Stratification of subjects based on amount of tobacco consumption identified SNPs that were associated with
either high or low tobacco exposed group. The study reveals a synergism between associated SNPs and lifestyle factors in
predisposition to OSCC and leukoplakia.
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Introduction
Oral squamous cell carcinoma (OSCC) is the tenth most
common cancer worldwide. In India, OSCC ranks first among
men and fourth among women [1], [2]. The oral cavity regions
that are affected by this cancer are tongue, buccal mucosa, lip and
gingiva. Known risk factors for oral cancer are tobacco chewing
and smoking, alcohol consumption, HPV infection and gender [3].
The incidence (9.8 in men, 5.2 in female per 10,0000 persons per
year) and mortality rate (22.1 in men, 9.4 in female per 100,000
persons per year) of OSCC escalated in Indian populations due to
an increasing rate (35%) of tobacco consumption [4], [5]. Among
various provinces of India, West Bengal population has high age
standardized tobacco related cancer mortality rate (33.4) and
cumulative risk 5.0% (99% confidence interval [CI] 4.1–5.8) [2].
The most common clinically presented premalignant lesion of
buccal mucosa is oral leukoplakia with a prevalence of 0.1–0.5%
and rate of transformation to cancer is 1–2% per year [6]. The
treatment and assessment of the risk and progression of
leukoplakia remains a problem, as it recurs despite of its removal
via surgery, and chemotherapy does not decrease cancer incidence
[7]. Thus, genetic marker based risk assessment is necessary for
early detection.
Numerous genetic association studies have identified SNPs in
several important genes like p53, p73 and MDM2 as risk factors to
OSCC and leukoplakia development [8–10]. A Genome Wide
Association Study (GWAS) on Upper Aerodigestive Tract Cancers
(UADT), that included the oral cavity regions, identified
susceptible variants mainly in aldehyde dehydrogenase (ADH) gene
cluster [11]. Cellular DNA repair processes stabilize the genome
by reducing carcinogen induced mutations [12]. However, studies
on repair gene variants and OSCC susceptibility focused mainly
on XRCC group of genes and on few other DNA repair associated
genes like ATM, NBN and MRE11A in different populations
worldwide [13], [14]. In Indian populations, association of
polymorphisms in XRCC1, XRCC3, NAT2, XPD, ERCC2 and
OGG1 with OSCC have been reported [15–19].
Double Strand Breaks (DSB), is considered to be the most lethal
among the different kind of damages [20] and Non Homologous
End Joining repair (NHEJ) is the major pathway for the DSB
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repair process [21]. The other DNA repair pathway that has been
reported to be compromised in OSCC is the MisMatch Repair
(MMR) pathway. The members of MMR play important roles in
reducing the mutation rate and genomic instabilities [12]. MLH1
and MSH2 of MMR are inactivated by promoter hyper-
methylation in OSCC [22]. These DNA repair genes are also
major targets for many anti-cancer drug development studies [23],
[24]. Polymorphisms in these genes modulate the individual
response to carcinogenic agents [25] and to drugs [26], [27].
We performed a case-control association study to identify risk
SNPs at major DSB repair (RAD50, MRE11A, NBS1, PRKDC,
XRCC5, XRCC6 and LIG4), MMR (MSH6 and MSH3) and key
DNA damage response (ATM and ATR) genes in oral cancer and
leukoplakia patients from the state of West Bengal of eastern India.
In the discovery phase we genotyped 321 SNPs in 626 cases (373
individuals with OSCC and 253 individuals with leukoplakia) and
535 age-matched controls with similar tobacco smoking and/or
chewing habits and no oral ailments. Subsequently, we validated
significantly associated SNPs in a separate replication cohort of
114 OSCC patients and 160 controls from the same geographic
locations. Finally, we performed a Multi Dimensionality Reduc-
tion (MDR) analysis to observe SNP-SNP and SNP-environment
interaction.
Methods
Ethics Statement
Procedures for collection of blood samples and written informed
consent form were reviewed and approved by the Institutional
Ethical Committee, CSIR-Indian Institute of Chemical Biology,
Kolkata, India.
Written informed consent was obtained from all case and
control subjects after explaining the collection procedures and
purpose of the study in local languages.
Subjects
In the discovery phase, 373 OSCC and 253 leukoplakia patients
were recruited between 2006 and 2009 from R. Ahemed Dental
College and Hospital, Kolkata India after pathologist from the
hospital confirmed these two types of lesion by histo-pathological
examinations. These patients are caste populations of low and
middle income group (annual family income ,$100 and ,$300,
respectively) from various districts of the state of West Bengal in
the eastern region of India. We, therefore, recruited 535 ethnically
matched but unrelated control individuals either from the same
hospital who have come to the hospital for dental and oral check
up and have no oral ailments and also directly from the population
by visiting various locations of the state of West Bengal. The
potential consequence of using hospital based control is biased
sampling which we have tested by principal component analysis
and adjusted the bias, if any. Control individuals recruited from
population were examined by physicians to ensure that individuals
without any oral ailments are enrolled. Both patients and controls
were regular tobacco users, either in the form of smoking and/or
chewing, at the time of collection. We divided both patients and
controls based on tobacco exposure level: (a) High Dose (HD) and
(b) Low Dose (LD) tobacco exposed groups. We computed tobacco
smoking and chewing index, PY (Pack Year) and CY (Chewing
Year), respectively by using the following formula as used in earlier
studies: (No. of cigarettes per day/206No. of years)+(No. of bidis
per day/406No. of years) for PY and (No. of times per day6No.
of years) for CY [28]. Next, we used median values of PY and CY
to divide the subjects in HD and LD groups. In the replication
phase, another 114 OSCC patients from Chittaranjan National
Cancer Research Institute, Kolkata, India and 160 controls were
recruited with the same inclusion and exclusion criteria. Fresh 5–
10 ml blood samples were collected with informed consent from
patients and controls. Information on age, sex, oral hygiene,
tobacco habits and alcohol consumptions were recorded by
interviewing both patients and controls.
Genes and SNP Selection
We selected seven key genes for selection of SNPs from DSB
repair pathway (LIG4, MRE11A, PRKDC, NBN, RAD50, XRCC5
and XRCC6), two major genes from MMR pathway (MSH6 and
MSH3) and two genes from DNA damage response pathway (ATM
and ATR). We chose all genes of NHEJ core repair machinery as it
is the major repair process of DSB pathway and also remain active
throughout the cell cycle compared to homologous recombination
repair process [21], [29]. The core component includes XRCC5
and XRCC6 that form a dimer and together with PRKDC
recognize the double strand breaks. Subsequently, the MRN
complex composed of MRE11A, RAD50 and NBN clean up the
ends and finally LIG4 seals the gap [29]. In mismatch repair
pathway, we focused our study on mismatch recognition process.
Two different complexes composed of MSH2-MSH3 and MSH2-
MSH6 recognizes mismatches and Insertion/Deletion Loops
(IDLs), respectively. Although many genetic association studies
have been performed in MSH2 in oral and colorectal cancer, the
genetic association of MSH3 and MSH6 in different cancers is only
beginning to be understood [30–34]. The ATM and ATR genes
selected from the DNA damage response pathway as these genes
are major signal transducers that initiate DNA damage related
signalling for repair [35], [36]. A ‘‘maximally informative’’ method
of SNP selection from HapMap data to non-HapMap populations
was applied to select SNPs [37]. For easy understanding, we have
provided the details and step by step process of this selection
algorithm with the permission of the authors in online supple-
mentary methods (Methods S1). The list of SNPs was submitted to
Illumina to estimate the GoldenGate assay success rate and finally
321 SNPs were selected for discovery phase analysis. In the
replication phase we genotyped only those SNPs that showed
significant association with the OSCC development (P-value
,0.05). Replication of the SNPs that were found to be associated
with the leukoplakia could not be done due to unavailability of a
new cohort of these patients in sufficient numbers.
Genotyping, Quality Control and Statistical Methods
Genomic DNA was isolated from peripheral blood leukocytes
using the QIAGEN blood DNA isolation kits as per manufacture
protocol. The concentration of DNA samples were estimated by
picogreen assay and diluted to a concentration of 50 ng/mL. The
Illumina GoldenGate assay (Illumina, San Diego, USA) was used
for genotyping in the discovery phase and in the replication phase
genotyping was performed by TaqMan assay in real time PCR
machine 7500 Fast and StepOne Plus (Applied Biosystems, Foster
City, USA). Both kind of genotyping were performed as per
manufacture’s protocol and we included 10% samples as replicate
in each platform to measure genotyping replication error. For
GoldenGate assay, we discarded data with a GenCall score ,0.25
as the potential outliers and checked controls and contamination
dashboards for each plate. For TaqMan, we used automated
clusters and checked FAM and VIC dye intensities, and cycle
threshold values in each plate. The software used for genotype call
were Illumina’s BeadStudio (version 2.3.43), StepOne (version 2.2)
and 7500 SDS (version 2.0.5).
To ensure high quality data in the final association analysis, we
discarded data on (a) SNPs that did not have valid genotype calls
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on .90% of sampled individuals, and (b) individuals for whom
genotype calls on.8% of the SNPs were missing. Further, data on
SNPs for which the Minor Allele Frequency (MAF) was,0.05 and
had a P value ,0.001 for departure from Hardy-Weinberg
equilibrium were also discarded. The study design is presented in
Fig. 1. The allelic and genotypic association tests were performed
in four different ways: (a) Case versus Controls (CC), where case
included both OSCC and leukoplakia samples; (b) Cancer versus
Controls (CAC), where only OSCC samples were considered as
cases; (c) Leukoplakia versus Control (LC) and (d) Cancer versus
Leukoplakia (CAL), where leukoplakia samples were considered as
controls. In each set, P-values, odds ratios (OR) and 95% CI were
determined by logistic regression using age, sex and tobacco habits
as covariates. Finally, all the unadjusted P-values were corrected
for multiple testing by Benjamini-Hochberg step up False
Discovery Rate control (FDR-BH) [38]. Additionally, to eliminate
any population stratification effect on the association tests, we
performed Identity-by-State (IBS) clustering of the genotyped data
and generated first four principal components. All four compo-
nents of PCA (Principal Component Analysis) were then used as
covariates along with other covariates as mentioned earlier for
allelic and genotypic association testing [39].
As tobacco habit is strongly associated with cancer develop-
ment, we also performed association analysis using tobacco
smoking and chewing as covariates in logistic regression. Subjects
were divided into high dose (HD) and low dose (LD) as described
above. Association P-value of the HD and LD groups were also
adjusted for age and sex by logistic regression and corrected by
FDR-BH.
Association tests, logistic regression, multiple testing corrections
and PCA were performed using PLINK [40]. The PCA data was
visualized by R [41], Mann-Whitney and chi-square tests in
Table 1 and Table 2 were performed online at http://faculty.
vassar.edu/lowry/utest.html and http://www.graphpad.com/
quickcalcs/contingency1.cfm, respectively. The power of the study
is calculated from http://www.stat.ubc.ca/˜rollin/stats/ssize/caco.
html.
MDR Analysis of SNP-SNP and SNP-environment
Interaction
To analyze possible interaction among the associated SNPs and
all the covariates, we used the non-parametric MDR approach, as
described previously [42]. MDR, a constructive induction process
[43], defines a single variable that incorporates information from
multi locus genotypes and other disease controlling factors and
store as either high or low disease risk group. We included
significant SNPs and all covariates (Age, Sex, PY and CY) to
construct interaction models separately in CC, CAC, LC and CAL
groups. Statistical significance was determined using permutation
testing in MDRpt (version 1.0_beta_2). We used 10 fold cross-
validation and 1000 fold permutation testing and considered those
interaction models as significant which showed a P-Value less than
0.05. Among the significant models, we identified important ones
which have a cross validation consistency (CVC) $9, as the data
was cross validated 10 times by MDR. The best model was then
defined with the largest testing balance accuracy (TBA) among the
important models. The MDR and MDRpt are open-source
software and freely available from http://www.epistasis.org.
We also build hierarchical interaction entropy graphs to quickly
access and interpret MDR models based on the theory of
information gain as described previously [44] using Orange
software package [45].
Results
Sample Ascertainment
We have presented distribution of age, sex, PY and CY of all the
samples recruited in the discovery and replication phase in online
Table 1 and 2, respectively. We found that some of the parameters
differed significantly in different comparison groups. We, there-
Figure 1. Overall strategy of the association study.
doi:10.1371/journal.pone.0056952.g001
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fore, adjusted age, sex and tobacco habit in all the association tests
by logistic regression. However, to assess the contribution of
tobacco exposure to disease predisposition, we also performed
association test without its adjustment after dividing the subjects
into high and low dose groups with discovery phase samples.
DNA Repair Gene Variants Confer Risk/Protection to
OSCC and Leukoplakia
In discovery phase, some of the genotyping data were removed
due to following reasons: (i) 13 individuals with ,92% genotyping
calls, (ii) 6 SNPs with ,90% genotyping calls, (iii) 18 SNPs
removed based on Hardy-Weinberg test with P-Value ,0.001,
and (iv) 108 SNPs removed for MAF ,0.05. In the final analysis
more than 98% genotyping rate was observed with 195 SNPs in
336 OSCC, 239 leukoplakia and 512 control samples. The
genomic inflation factor (l) of the QC dataset was 1 to 1.01. We
found that the power of the study is 81%, which is considered as
sufficient for the identification of associations.
Table 3 provides P-values for different association tests such as:
(a) without any adjustment of covariates [age, sex and tobacco
habit by logistic regression] and corrections for multiple testing
[Benjamini-Hochberg FDR for multiple testing], (b) without any
covariate adjustment but with correction for multiple testing, (c)
with covariate adjustments but no multiple testing correction and
(d) with both covariate adjustments and multiple testing correc-
tion. We found rs12515548 of MSH3 to be significantly associated
with the CC group [P-value 7.83E-03, OR: 1.733 (1.333–2.254)].
Significance of this association increased when comparison was
made separately between oral cancer and control (Table 3).
Another SNP rs207943 of XRCC5 also showed significant
association with oral cancer. Interestingly, these two SNPs were
also found to be significantly associated with OSCC when
compared to leukoplakia samples as control (Table 3). These
results suggest that they have strong influence on predisposition to
oral cancer whether or not they are presented as premalignant
lesions. Two other loci (rs7003908 of PRKDC and rs12360870 of
MRE11A) showed exclusive associations with leukoplakia; one
being risk (rs12360870) and the other protective (rs7003908). The
significant allelic association of rs12515548, rs207943 and
rs12360870 also remained significant at the genotypic level (Table
S1).
We performed stratification analysis to verify the confounding
effect of evolutionary genetic heterogeneity within the studied
population on the association results. Similar clustering was
observed on both cases and controls (Fig. S1). Interestingly, similar
clustering was also observed when analysis was done based on
sample type (i.e. OSCC, leukoplakia and controls, Fig. S1) or
geographical locations (Fig. S1). We next performed association
test in CC group using first four principal components as
covariates. The SNP rs12515548 of the MSH3 remained
significant [allelic association P-value: 0.006, OR: 1.1717
(1.318–2.236)] as it was observed without the stratification
adjustment. We continued this analysis in all four groups (CC,
CAC, LC and CAL) and found that no associated variants were
excluded due to the observed clustering (Table S2).
Tobacco Exposure Modifies the Effect of DNA Repair
Gene Variants on Oral Cancer and Leukoplakia
Predisposition
We performed association analysis using tobacco exposure as
covariate to better understand its role in oral cancer and
leukoplakia in the discovery phase samples. Table 4 shows that
Table 1. Basic characteristics of case and control data in discovery phase.
Parameters Con (n =535) Case (Can+ Leu) (n=625) Can (n =373) Leu (n=253) P-value
Case- Con Can - Con Leu- Con Can - Leu
Age Range 22–85 20–88 25–88 20–75 ,0.001a ,0.001a 0.458a ,0.001a
Median 48 50 55 46
Sex Male 379 443 230 213 0.353b 0.103b ,0.001b ,0.001b
Female 156 160 121 39
M:F Ratio 2.42 2.76 1.9 5.46
Pack Year Range 0.13–98.33 1–90 1–75 1–90 0.175a 0.001a ,0.001a ,0.001a
Median 15 15 15 15
Chewing Year Range 0.51–960 3–1000 4–1000 3–720 0.153a ,0.001a ,0.001a ,0.001a
Median 115 111.5 120 80
Abbreviation: Con: Control, Can: Oral cancer, Leu: Leukoplakia.
aP-values from Mann-Whitney test,
bp-values from chi-square test.
doi:10.1371/journal.pone.0056952.t001
Table 2. Basic characteristics of cancer and control in
replication phase.
Parameters
Control
(n = 160)
Cancer
(n =114) P-value
Age Range 20–80 27–81 0.221a
Median 51 53
Sex Male 116 76 0.3491b
Female 44 38
M:F Ratio 2.636 2
Pack Year Range 1–74.12 0.63–71 0.917a
Median 15 16.5
Chewing Year Range 1–980 3.45–893.5 0.733a
Median 120 100
Abbreviation:
ap-values from Mann-Whitney test,
bP-values from chi-square test.
doi:10.1371/journal.pone.0056952.t002
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most of the comparative groups exhibited association with the low-
dose (LD) tobacco exposure level. The two significantly associated
SNPs with OSCC (rs12515548 and rs207943) also showed
significant association with low-dose tobacco exposure group.
Interestingly, these two SNPs also showed association with low
dose tobacco group when compared between cancer and
leukoplakia where leukoplakia was considered as reference
(CAL-LD in Table 4). Carriers of two SNPs (rs12360870 of
MRE11A and rs7003908 of PRKDC) continued to show similar
effects (one being risk and other protective) on leukoplakia
development when exposed to both high and low-dose of tobacco
(LC-LD and LC-HD in Table 4). These results suggest their strong
role on OSCC predisposition irrespective of tobacco exposure
level. Table S3 shows association results at the genotypic level. We
found all the significant variants from allelic association remained
significant in genotypic tests also, except rs7003908 of PRKDC.
Validation of Selected SNPs in OSCC-control Replication
Cohort
Next, we genotyped rs12515548 of MSH3 and rs207943 of
XRCC5 in a separate cohort of 114 OSCC patients and 160
control subjects to validate the discovery phase results. The
unavailability of a separate cohort of leukoplakia samples
prevented us from validation of rs12360870 and rs7003908 that
were found to be significantly associated exclusively with
leukoplakia samples in the discovery phase. We found only
rs12515548 remained significantly associated with OSCC in both
allelic and genotypic analysis (replication P-value: allelic 4.83E-03,
genotypic 0.044; Table 5 and Table S4). The combined P-values
for this SNP of discovery and replication phase for allelic and
genotypic tests are 1.21E-06 and 0.009, respectively.
SNP-SNP and SNP-environment Interaction Reveals
Moderate Synergistic Effects
We performed MDR analysis to reveal the SNP-SNP and SNP-
environment factors interactions in this cohort of individuals. We
found the most potent interaction in OSCC as compared with
control is between rs207943, rs12515548, Age and tobacco
smoking with a TBA of 0.6011 and CVC 10 (p-value 0.001).
However, the most significant model for OSCC development form
leukoplakia was the interaction among rs207943, rs12515548, sex
and tobacco chewing (Table S5). For leukoplakia development
from control, the most significant model was the interaction of all
covariates with rs12360970 followed by inclusion of rs7003908
(Table S5).
Next, we applied interaction entropy algorithms to support
interpretation of the relationship between the variables. We found
the most potent model of OSCC (CAC) as revealed from
permutation testing (rs207943-rs12515548-Age-PY) is synergistic
in nature (Fig. 2A). Interestingly, the age and sex contributes to
this interaction in an independent manner with an entropy
removal of 1.43% and 0.56%, respectively. The synergistic
interaction was also observed in the model consisting of
rs207943, rs12515548, Sex and CY for OSCC development from
leukoplakia (CAL), where all factors work jointly (Fig. 2B). We
found age in the CAC comparison and tobaccos chewing in CAL
comparison are the most important covariates with 5% and 7.12%
entropy removal, respectively. For leukoplakia development
rs12360870 is the strongest factor (entropy explained: 6.35%)
and all significant interactions are synergistic (Fig. 2C). The model
for CC comparison resembled both CAC and LC comparisons
(Fig. 2D).
Discussion
The regional genetic and lifestyle heterogeneity among popu-
lations from different parts of India have been noted by many
investigators [46–48]. This poses serious impediment to the
genetic association study in Indian populations. We thus, targeted
the middle and low-income group of semi-urban population with
an age range of 22 to 80 years from the state of West Bengal in this
study. We also ensured similar tobacco habits of the case and
control individuals who participated in the study. The ongoing
Million Death Study (MDS) in India finds an increase in age-
specific cancer risk due to tobacco habit in the population from
West Bengal [2]. Another study also reported association of oral
habit and DNA damage with OSCC and leukoplakia in these
populations [49].
The most promising associated SNP from this study is
rs12515548 of MSH3. This SNP was found to be significantly
associated in three out of four analysis sets tested in the discovery
phase (case-control, cancer-control and cancer-leukoplakia) and
also remained significant in the replication phase. No association
was found with this SNP in GWAS of upper aerodigestive tract
cancers and this is the first report of association of this SNP with
OSCC. However, several studies showed association of other
SNPs in MSH3 and MSH6 genes in different cancers [33], [50],
[51]. It may be noted that, although we have observed relatively
strong P-values in the association tests for the given sample size,
the power of the study is 0.81 and there was no population
stratification. However, further replication is essential in same and
other populations. The rs12515548 is an intronic SNP located
near 21th exon of the MSH3 with a change from G to A (http://
Table 4. Allelic associations in with respect to tobacco
exposure.
Gene
SNP
(Major/Minor
Alleles) MAFa Testb OR (95% CI)
P-
valuesc
MSH3 rs12515548
(A/G)
0.089 CC-HD 1.385 (0.997–1.922) 0.558
CC-LD 1.837 (1.398–2.413) 2.48E-03
0.089 CAC-HD 1.718 (1.202–2.456) 0.15
CAC-LD 3.37(1.893–6.001) 2.48E-06
0.101 CAL-HD 1.756 (1.097–2.81) 0.568
CAL-LD 2.251 (1.533–3.303) 3.21E-03
XRCC5 rs207943
(C/G)
0.358 CAC-HD 1.505 (1.149–1.972) 0.15
CAC-LD 1.767 (1.433–2.178) 9.57E-06
0.336 CAL-HD 1.68 (1.231–2.292) 0.073
CAL-LD 1.771 (1.38–2.273) 7.30E-04
MRE11A rs12360870
(G/A)
0.279 LC-HD 2.264 (1.702–3.013) 4.09E-06
0.295 LC-LD 1.796 (1.45–2.224) 1.58E-05
PRKDC rs7003908
(A/C)
0.088 LC-HD 0.162 (0.062–0.427) 0.023
0.105 LC-LD 0.212 (0.113–0.399) 1.43E-04
aMAF: Minor allele frequency of the reference population is listed;
bAssociation tests abbreviations, CC: case (jointly oral cancer and leukoplakia)
vs. Control, CAC: cancer vs. Control, CAL: cancer vs. Leukoplakia, LC: leukoplakia
vs. control, HD: High-dose and LD: Low-dose tobacco exposed group;
cBenjamini-Hochberg False Discovery Rate corrected P-values for multiple tests.
doi:10.1371/journal.pone.0056952.t004
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www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs = 12515548).
Two functional attributes may be associated with this SNP, (a)
functionality prediction using F-SNP [52] revealed that it loses the
capacity to bind GATA family of transcription factors upon
change from G to A (confidence score of binding prediction for
different GATA transcription factors ranges from 88.4 to 98.4)
and (b) the miRBase analysis showed an increased affinity of hsa-
miR-374a-3p to the risk allele (A) of the SNP (score 6.9, evalue 1.0
for allele A; score 60, evalue 5.6 for allele G). Direct experimental
validations are needed to understand its exact functional role, if
any. The results from Indian Genome Variation Consortium [47]
and admixture mapping of Indian population identified the caste
populations of the eastern India as Indo-European population
which show relatedness to the CEU population of the HapMap
[53], [54]. We thus, build a LD map of MSH3 using imputed data
from HapMap CEU population and found an 81 Kb LD block
with rs12515548 which includes exon 21 (data not shown). It
would be interesting to examine whether or not such LD block
exist in this populations and, if so, whether rs12515548 is linked
with any other functional SNP of the MSH3. The intronic SNP
rs207943 of XRCC5, which also showed significant association
with OSCC development, is present within a putative binding site
of the transcription factor Skn-1 of C. elegans. It binds only with
non-risk G allele of the SNP (F-SNP prediction score 0.5, binding
score 87.1). The human homolog of Skn-1, Nrf 1/2/3 is an
important transcription factor involved in oxidative stress
resistance [55]. The Nrf2 deficient mice have attenuated
expressions of many detoxifying and antioxidant enzymes and
are highly susceptible to carcinogen induced toxicity and
carcinogenesis [56]. Thus, the inability of Skn-1 binding with
the risk allele C of this SNP and OSCC progression needs to be
investigated further.
The study also probed genetic risk factors associated with the
development of leukoplakia and its conversion to OSCC. We
found different SNPs to be associated exclusively with the
development of leukoplakia from normal individuals and progres-
sion of leukoplakia to cancer. For example, rs7003908 of PRKDC
was reported to be associated with prostate and urinary bladder
cancer in north-Indian populations and glioblastoma in United
States [57–59]. Identification of a specific risk SNP associated with
cancer-leukoplakia comparison would be valuable as a prognostic
biomarker for the detection of cases where leukoplakia would have
the potential of conversion to oral cancer. However, replication of
the association in another cohort of leukoplakia patients is
required to validate these results.
The tobacco exposure is a known environmental factor
associated with oral cancer and leukoplakia. Thus, we performed
association test without its adjustment and stratifying the subjects
based on their tobacco exposure levels. The observation that a few
polymorphic variants of DNA repair and damage response genes
exhibited association to a different tobacco exposed groups
suggests that DNA damage signals are differentially processed by
different polymorphic variants of these genes. Similar observation
has also been made in previous studies with p53 gene polymor-
phisms [28]. It may be noted that these SNPs might be useful for
development of tobacco-associated predictive marker for oral
cancer and leukoplakia. The MDR analysis revealed age in OSCC
and chewing in leukoplakia are the two important covariates
which interacts synergistically with the most potent risk SNPs of
the respective diseases (rs12515548 and rs207943 for OSCC and
rs12360870 for leukoplakia). The study revealed synergy between
SNPs and redundancy between lifestyle factors albeit without any
additive effect. This particular phenomena was also observed with
the SNPs from DNA repair genes in other caner types [60]. Thus,
it may be suggested that the overall repair capacity contributed by
different repair machineries and independent effects of various
lifestyle factors are the ultimate determinant of oral cancer and
leukoplakia predisposition in an individual.
The present study suggests that MSH3, XRCC5, MRE11A and
PRKDC to be the four most important genes that would modify the
risk of predisposition to oral cancer and leukoplakia in these
eastern Indian populations. Polymorphic variants of these genes
were found to be significantly associated with breast, pancreatic,
colorectal and ovarian cancers [61–64]. However, to the best of
our knowledge, none of the variants identified in this study were
previously reported to be associated with any other cancer, except
rs7003908. MSH3 upon phosphorylation by ATM/ATR initiates
DNA mismatch repair with MSH2 and directs downstream MMR
events, including strand discrimination, excision, and re-synthesis
with MLH1 and PMS1 [36], [65]. XRCC5 with XRCC6 forms a
dimer and increases the affinity of PRKDC, the catalytic subunit
of DNA-PK [DNA-dependent serine/threonine protein kinase]
[66]. It plays several crucial roles like, recognition and recruitment
of other components to DSB and phosphorylation of several
transcription factors including p53 [67]. Several other phosphor-
ylating substrates of PRKDC have also crucial role in cancer, like,
c-Myc, PARP, c-JUN [68–70]. MRE11A, one of the partners of
MRE11A-RAD50-NBN complex involved in DSB repair, have
also role in telomerase integrity and meiosis. The functional
implications of either the associated intronic SNPs or their linked
functional SNPs in these genes are needed to be investigated in
future.
Table 5. Allelic association results of replication study and comparison with discovery data.
Gene
SNP
(Minor/Major Allele) Phase of study MAFb OR (95% CI) P-value
MSH3 rs12515548
(A/G)
Replication 0.097 4.424 (1.572–12.45) 4.84E-03#
Discovery 0.096 2.231 (1.666–2.988) 1.43E-05*
XRCC5 rs207943
(C/G)
Replication 0.363 1.065 (0.474–2.392) 0.8796#
Discovery 0.364 1.734 (1.412–2.129) 1.43E-05*
aMAF: Minor allele frequency of the reference population is listed;
*Benjamini-Hochberg False Discovery Rate corrected P-values for multiple tests;
#Unadjusted P-values.
doi:10.1371/journal.pone.0056952.t005
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